{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:52:07Z","timestamp":1786996327181,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.rmed.2025.108074","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T23:04:20Z","timestamp":1743548660000},"page":"108074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms"],"prefix":"10.1016","volume":"241","author":[{"given":"Robinson E.","family":"Robles-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8107-1788","authenticated-orcid":false,"given":"Francisco","family":"Montiel-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Vel\u00e1zquez-Uncal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal H.","family":"Sansores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Hern\u00e1ndez-Zenteno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"P\u00e9rez-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-5753","authenticated-orcid":false,"given":"Alejandra","family":"Ram\u00edrez-Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108074_bib2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2147\/COPD.S268110","article-title":"Prevalence of chronic obstructive pulmonary disease and its associated factors in Nepal: findings from a community-based household survey","volume":"15","author":"Adhikari","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2025.108074_bib3","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2147\/COPD.S417600","article-title":"Association of exposure to biomass fuels with occurrence of chronic obstructive pulmonary disease in rural western China: a real-world nested case-control study","volume":"18","author":"Zhang","year":"2023","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2025.108074_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modeling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib5","first-page":"23","article-title":"Clinical characteristics of patients with biomass smoke-associated COPD and chronic bronchitis, 2004-2014","volume":"1","author":"P\u00e9rez-Padilla","year":"2014","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.rmed.2025.108074_bib6","series-title":"Chronic Obstructive Pulmonary Disease (COPD)","year":"2024"},{"key":"10.1016\/j.rmed.2025.108074_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4149\/BLL_2022_005","article-title":"Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice","volume":"123","author":"Lassan","year":"2021","journal-title":"BLL"},{"key":"10.1016\/j.rmed.2025.108074_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13063-021-05163-2","article-title":"Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial","volume":"22","author":"Siddharthan","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.rmed.2025.108074_bib9","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol\u2013glycopyrronium versus salmeterol\u2013fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12931-020-1310-9","article-title":"Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease","volume":"21","author":"Salvi","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108074_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.700836","article-title":"The \u201cslow horse racing effect\u201d on lung function in adult life in chronic obstructive pulmonary disease associated to biomass exposure","volume":"8","author":"Ram\u00edrez-Venegas","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1183\/09031936.00206112","article-title":"COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women","volume":"43","author":"Camp","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108074_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0196-2021","article-title":"The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review","volume":"31","author":"Calzetta","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108074_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-020-1152-8","article-title":"Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis","volume":"20","author":"Koarai","year":"2020","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thoraxjnl-2011-201518","article-title":"Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality","volume":"67","author":"Suissa","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2025.108074_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00154-2024","article-title":"Effectiveness of ICS\/LABA and LAMA\/LABA in COPD due to biomass","volume":"10","author":"Ram\u00edrez-Venegas","year":"2024","journal-title":"ERJ Open Research"},{"key":"10.1016\/j.rmed.2025.108074_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108074_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1164\/ajrccm.154.3.8810608","article-title":"Exposure to biomass smoke and chronic airway disease in Mexican women. A case-control study","volume":"154","author":"P\u00e9rez-Padilla","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108074_bib19","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation: the st. George's respiratory questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.rmed.2025.108074_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4104\/pcrj.2009.00053","article-title":"Improving the process and outcome of care in COPD: development of a standardised assessment tool","volume":"18","author":"Jones","year":"2009","journal-title":"Prim. Care Respir. J."},{"key":"10.1016\/j.rmed.2025.108074_bib21","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/COPD.S82408","article-title":"Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease","author":"Perez","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2025.108074_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108074_bib23","doi-asserted-by":"crossref","DOI":"10.1590\/S0036-36342001000200006","article-title":"Reproducibilidad de espirometr\u00edas en trabajadores mexicanos y valores de referencia internacionales","volume":"43","author":"P\u00e9rez-Padilla","year":"2001","journal-title":"Salud Publica Mex."},{"key":"10.1016\/j.rmed.2025.108074_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1183\/09031936.04.00120603","article-title":"The TORCH (TOwards a Revolution in COPD Health) survival study protocol: fig. 1","volume":"24","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108074_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib26","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/COPD.S201314","article-title":"Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial","volume":"14","author":"Ram\u00edrez-Venegas","year":"2019","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2025.108074_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1152\/japplphysiol.00332.2021","article-title":"A randomized, crossover, placebo controlled, double-blind trial of the effects of tiotropium-olodaterol on neuromuscular performance during exercise in COPD","volume":"132","author":"Cao","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2025.108074_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12890-021-01403-y","article-title":"A randomized controlled trial of long-acting muscarinic antagonist and long-acting \u03b22 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease","volume":"21","author":"Muraki","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2025.108074_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-018-0721-3","article-title":"Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis","volume":"19","author":"Di Marco","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2025.108074_bib30","first-page":"972","article-title":"Comparison of lung morphology in COPD secondary to cigarette and biomass smoke","volume":"12","author":"Rivera","year":"2008","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.rmed.2025.108074_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1590\/S1806-37132013000200005","article-title":"Tomographic and functional findings in severe COPD: comparison between the wood smoke-related and smoking-related disease","volume":"39","author":"Gonz\u00e1lez-Garc\u00eda","year":"2013","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.rmed.2025.108074_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/S1806-37132013000200006","article-title":"Pulmonary changes on HRCT scans in nonsmoking females with COPD due to wood smoke exposure","volume":"39","author":"Moreira","year":"2013","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.rmed.2025.108074_bib33","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198233","article-title":"Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD","volume":"52","author":"Meneghini","year":"2019","journal-title":"Braz. J. Med. Biol. Res."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:06:42Z","timestamp":1752574002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"alternative-id":["S0954611125001362"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108074","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108074"}}